William C. Rees

564 total citations · 1 hit paper
8 papers, 429 citations indexed

About

William C. Rees is a scholar working on Dermatology, Rheumatology and Physiology. According to data from OpenAlex, William C. Rees has authored 8 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 5 papers in Rheumatology and 5 papers in Physiology. Recurrent topics in William C. Rees's work include Dermatology and Skin Diseases (8 papers), Asthma and respiratory diseases (5 papers) and Urticaria and Related Conditions (5 papers). William C. Rees is often cited by papers focused on Dermatology and Skin Diseases (8 papers), Asthma and respiratory diseases (5 papers) and Urticaria and Related Conditions (5 papers). William C. Rees collaborates with scholars based in United States, Indonesia and Canada. William C. Rees's co-authors include Lawrence F. Eichenfield, Amy S. Paller, Adelaide A. Hebert, Wynnis L. Tom, Douglass W. Forsha, Robert S. Call, Lee T. Zane, Mark Lebwohl, Mary Spellman and Andrea L. Zaenglein and has published in prestigious journals such as The Journal of Immunology, PEDIATRICS and Journal of Allergy and Clinical Immunology.

In The Last Decade

William C. Rees

8 papers receiving 416 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

2016 415 citations Amy S. Paller, Wynnis L. Tom et al. Journal of the American Academy of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William C. Rees United States	4	375	297	109	71	33	8	429
Douglass W. Forsha United States	4	485 1.3×	394 1.3×	151 1.4×	87 1.2×	43 1.3×	15	562
Andrea Waldman United States	8	317 0.8×	264 0.9×	99 0.9×	42 0.6×	29 0.9×	12	366
William D. Boothe United States	4	306 0.8×	185 0.6×	65 0.6×	52 0.7×	61 1.8×	7	373
Alan Clucas France	10	373 1.0×	138 0.5×	73 0.7×	69 1.0×	61 1.8×	13	476
Akiko Takaoka Japan	9	250 0.7×	140 0.5×	170 1.6×	88 1.2×	189 5.7×	18	486
Claire Clibborn United States	6	284 0.8×	199 0.7×	92 0.8×	81 1.1×	39 1.2×	16	317
F.M. Garritsen Netherlands	10	274 0.7×	192 0.6×	92 0.8×	30 0.4×	61 1.8×	16	314
Evelien Roekevisch Netherlands	5	417 1.1×	350 1.2×	157 1.4×	51 0.7×	34 1.0×	8	438
E S Fedenko Russia	8	158 0.4×	154 0.5×	69 0.6×	31 0.4×	44 1.3×	48	240
Laura Bonzano Italy	9	129 0.3×	141 0.5×	88 0.8×	39 0.5×	23 0.7×	22	231

Countries citing papers authored by William C. Rees

Since Specialization

Citations

This map shows the geographic impact of William C. Rees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Rees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Rees more than expected).

Fields of papers citing papers by William C. Rees

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Rees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Rees. The network helps show where William C. Rees may publish in the future.

Co-authorship network of co-authors of William C. Rees

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Rees. A scholar is included among the top collaborators of William C. Rees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Rees. William C. Rees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Paller, Amy S., Wynnis L. Tom, Mark Lebwohl, et al.. (2018). Phase 3 Studies Treating Children and Adult Patients with Mild to Moderate Atopic Dermatitis with Crisaborole Ointment, a Novel, Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor. PEDIATRICS. 141(1_MeetingAbstract). 275–275. 1 indexed citations

Paller, Amy S., Gil Yosipovitch, Wynnis L. Tom, et al.. (2018). Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials. PEDIATRICS. 142(1_MeetingAbstract). 814–814. 1 indexed citations

Paller, Amy S., Wynnis L. Tom, Robert S. Call, et al.. (2016). 286 Phase 3 studies in atopic dermatitis with the novel, nonsteroidal topical phosphodiesterase 4 inhibitor, crisaborole. Journal of Investigative Dermatology. 136(5). S50–S50. 3 indexed citations

Paller, Amy S., Wynnis L. Tom, Robert S. Call, et al.. (2016). 033 A novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase inhibitor, Crisaborole Topical Ointment, 2%, in two phase 3 studies in children and adults with mild to moderate atopic dermatitis. Journal of Investigative Dermatology. 136(9). S166–S166. 3 indexed citations

Paller, Amy S., Wynnis L. Tom, Mark Lebwohl, et al.. (2016). Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. Journal of the American Academy of Dermatology. 75(3). 494–503.e6. 415 indexed citations breakdown →

Boguniewicz, Mark, Amy S. Paller, Wynnis L. Tom, et al.. (2016). Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 137(2). AB397–AB397. 3 indexed citations

Paller, Amy S., Wynnis L. Tom, Mark Lebwohl, et al.. (2016). Two phase 3 studies in atopic dermatitis with crisaborole, the novel, nonsteroidal topical phosphodiesterase 4 inhibitor. 33. 2 indexed citations

Zane, Lee T., Amy S. Paller, Wynnis L. Tom, et al.. (2016). Two phase 3 study results of children and adults with mild-to-moderate atopic dermatitis treated with Crisaborole Topical Ointment, 2%, a novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase 4 inhibitor. The Journal of Immunology. 196(1_Supplement). 191.26–191.26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact